Connect with us

News

Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares

Published

8 months ago

on

August 30, 2023

By

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval.

AJ Mast | Bloomberg | Getty Images

Source: CNBC

Follow us on Google News to get the latest Updates

Related Topics:Biotech and Pharmaceuticals biotechnology Breaking News: Markets Bristol-Myers Squibb Co business news Eli Lilly and Co Featured Investment strategy Jim Cramer Johnson & Johnson Markets Merck & Co Inc stock takes VanEck Pharmaceutical ETF

Advertisement

News2 hours ago

Chinese EV makers zooming by pioneer Tesla – Asia Times

Lifestyle1 hour ago

Colin Jost Wins Over Tough White House Correspondents Dinner Crowd With Praise for ‘Decent’ Biden

News3 hours ago

Biden places politics over strategy in US Steel sale – Asia Times

There’s never been a better time to get into Fallout 76

Wellness3 hours ago

I Was Told I Had an STI. It Was Actually Cervical Cancer

Hong Kong exports rebound despite Sino-US trade war – Asia Times

Tech2 hours ago

Seattle mayor joins tech leaders on Homeland Security’s new AI safety and security board

News3 hours ago

‘SNL’ Star Colin Jost Ends Brutal Roast With Heartfelt Biden Endorsement